期刊文献+

Relationship between COX-2 expression and clinicopathological features of colorectal cancers 被引量:24

Relationship between COX-2 expression and clinicopathological features of colorectal cancers
原文传递
导出
摘要 Background Cyclo-oxgenase 2 (COX-2) is involved in prostaglandin synthesis in central nervous system, and it also plays a role in human carcinogenesis Our purpose of this study is to investigate the COX-2 expression in different development stages of colorectal cancer, and to discuss the relationship between the gene expression and clinicopathological features of the cancer Methods COX-2 expression was examined by immunohistochemical staining in 76 surgical specimens of colorectal cancer (44 of advanced stage and 32 of early stage), thirty-three adenomas and 18 normal colonic mucosal tissues taken by endoscopic biopsy Kaplan-Meier survival curves and Cox proportional hazards regression were used to evaluate the relation of COX-2 to prognosis Results COX-2 expression, divided into 4 grades from “-” to“+++”, is respectively 83 3%, 16 7%, 0% and 0% in normal colonic mucosal tissues; 12 1%, 42 4%, 36 4% and 9 1% in adenomas; 6 3%, 28 1%, 46 9% and 18 7% in early colorectal cancers (ECCs), and 6 8%, 20 5%, 18 2% and 54 5% in advanced colorectal cancers (CRCs) The differences in COX-2 expression between advanced CRCs and early colorectal cancers (ECCs) as well as between the advanced CRCs and adenomas were statistically significant ( P <0 01); but there was no significant difference between ECCs and adenomas Kaplan-Meier survival analysis showed a significant difference in the survival curves between low high COX-2 groups ( P <0 05) Cox proportional hazards regression showed that COX-2 expression was related to poorer long-term outcome with a hazard ratio of 2 665 unadjusted for other variables ( P <0 05), and COX-2 expression was an independent risk factor of poor prognosis KH*2/5DConclusions COX-2 expression is gradually up-regulated in the development from normal epithelium to adenomas and from ECCs to advanced CRCs Alhough the COX-2 protein can not be regarded as a tumor marker to diagnose CRCs early, COX-2 expression can be regarded as an independent risk factor of poor prognosis for postoperative patients with advanced CRCs Background Cyclo-oxgenase 2 (COX-2) is involved in prostaglandin synthesis in central nervous system, and it also plays a role in human carcinogenesis Our purpose of this study is to investigate the COX-2 expression in different development stages of colorectal cancer, and to discuss the relationship between the gene expression and clinicopathological features of the cancer Methods COX-2 expression was examined by immunohistochemical staining in 76 surgical specimens of colorectal cancer (44 of advanced stage and 32 of early stage), thirty-three adenomas and 18 normal colonic mucosal tissues taken by endoscopic biopsy Kaplan-Meier survival curves and Cox proportional hazards regression were used to evaluate the relation of COX-2 to prognosis Results COX-2 expression, divided into 4 grades from “-” to“+++”, is respectively 83 3%, 16 7%, 0% and 0% in normal colonic mucosal tissues; 12 1%, 42 4%, 36 4% and 9 1% in adenomas; 6 3%, 28 1%, 46 9% and 18 7% in early colorectal cancers (ECCs), and 6 8%, 20 5%, 18 2% and 54 5% in advanced colorectal cancers (CRCs) The differences in COX-2 expression between advanced CRCs and early colorectal cancers (ECCs) as well as between the advanced CRCs and adenomas were statistically significant ( P <0 01); but there was no significant difference between ECCs and adenomas Kaplan-Meier survival analysis showed a significant difference in the survival curves between low high COX-2 groups ( P <0 05) Cox proportional hazards regression showed that COX-2 expression was related to poorer long-term outcome with a hazard ratio of 2 665 unadjusted for other variables ( P <0 05), and COX-2 expression was an independent risk factor of poor prognosis KH*2/5DConclusions COX-2 expression is gradually up-regulated in the development from normal epithelium to adenomas and from ECCs to advanced CRCs Alhough the COX-2 protein can not be regarded as a tumor marker to diagnose CRCs early, COX-2 expression can be regarded as an independent risk factor of poor prognosis for postoperative patients with advanced CRCs
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2004年第8期1151-1154,共4页 中华医学杂志(英文版)
基金 ThisinvestigationwaspartlysupportedbytheGuangdongprovinceNatureScienceFund (No 0 13 14 7)
关键词 COX-2 colorectal cancer PROGNOSIS Cox proportional hazards regression COX-2 · colorectal cancer · prognosis · Cox proportional hazards regression
  • 相关文献

参考文献10

  • 1Yokoyama C,Tanabe T.Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme[].Biochemical and Biophysical Research Communications.1989
  • 2Kosaka T,Miyata A,Ihara H,et al.Characterization of the human gene( PTGS2 ) encoding prostaglandin-endoperoxide synthase 2[].European Journal of Biochemistry.1994
  • 3Dubois RN,Abramson SB,Crofford L.Cyclooxygenase in biology and disease[].The FASEB Journal.1998
  • 4Eberhart CE,Coffey RJ,Radhika A,et al.Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas[].Gastroenterology.1994
  • 5RistimakiA,HonkanenN,JankalaH,etal.Expressionofcy clooxygenase 2inhumangastriccarcinoma[].Cancer Research.1997
  • 6Shiota G,,Okubo M,Noumi T, et al.Cyclooxygenase-2 expression in hepatocellular carcinoma[].Hepato Gastroenterology.1999
  • 7Hwang D,Scollard D,Byrne J, et al.Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer[].Journal of the National Cancer Institute.1998
  • 8Wolff H,Saukkonen K,Anttila S,et al.Expression of cyclooxygenase-2 in human lung carcinoma[].Cancer Research.1998
  • 9Sano H,Kawahito Y,Wilder RL,et al.Expression of cyclo-oxygenase-1 and-2 in human colorectal cancer[].Cancer Research.1995
  • 10Giardiello FM,Hamilton SR,Krush AJ.Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis[].The New England Journal of Medicine.1993

同被引文献71

引证文献24

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部